Chargement en cours...
Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight
Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are newly approved class of oral anti-diabetic drugs, in the treatment of type 2 diabetes, which reduces blood glucose through glucouresis via the kidney, independent, and irrespective of available pancreatic beta-cells. Studies conducted across t...
Enregistré dans:
| Publié dans: | Indian J Endocrinol Metab |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673799/ https://ncbi.nlm.nih.gov/pubmed/26693421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.167554 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|